Tumour volume of PLX4720 + anti-PD-1-treated mice was 186 ± 59 at week 2, and 235 ± 41 at week 3; tumour size of PLX4720 + anti-PD-L1-treated mice was 235 ± 53 at week 2, and 270 ± 109 at week 3 (Fig. 1b). This evidence concerns the gene CD274 and neoplasm.